{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:57:21Z","timestamp":1774583841034,"version":"3.50.1"},"reference-count":51,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T00:00:00Z","timestamp":1245628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We report a retrospective and descriptive study of four immunocompromised patients (three with HIV\u20101 and one with idiopathic CD4+\u2010lymphopenia) with relapsing visceral leishmaniasis seen at the Hospital for Tropical Diseases, London, in whom pentamidine was used as secondary prophylaxis to prevent relapse. Patients experienced between one and four relapses before commencing prophylaxis with subsequent relapse\u2010free periods ranging from 5 to 98 months. Based on these observational data, we recommend large trials to investigate the efficacy of pentamidine over other agents in preventing relapse of VL in the immunocompromised patient.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2009.02329.x","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T01:51:36Z","timestamp":1245721896000},"page":"1064-1070","source":"Crossref","is-referenced-by-count":29,"title":["Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases"],"prefix":"10.1111","volume":"14","author":[{"given":"T. A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. N.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,24]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.2.298"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709465"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220104"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012220-00020"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(80)90275-0"},{"key":"e_1_2_4_7_1","first-page":"169","article-title":"Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV","volume":"15","author":"Borrelli P","year":"2000","journal-title":"Annali Italiani di Medicina Interna"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318166af5d"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00795.x"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.10.005"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2001.13.6.653"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112209"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100960100457"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.2.187"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(92)90297-P"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349803225002499"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.4.827"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199606001-00014"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/587899"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90281-F"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01700556"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199906180-00009"},{"key":"e_1_2_4_23_1","first-page":"222","article-title":"Prophylaxis of visceral leishmaniasis in human immunodeficiency virus\u2010infected patients","volume":"102","author":"Laguna\u2010del\u2010Estal P","year":"1997","journal-title":"The American Journal of Medicine"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199307000-00020"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/32.4.657"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349803225002615"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.58.436"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh084"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-2977(94)00109-M"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.1999.0607"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199202000-00020"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.2.362"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199212000-00013"},{"key":"e_1_2_4_34_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4269\/ajtmh.2004.70.298","article-title":"Frequency of visceral leishmaniasis relapses in human immunodeficiency virus\u2010infected patients receiving highly active antiretroviral therapy","volume":"70","author":"Mira JA","year":"2004","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(90)93933-J"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2003.09.012"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.142"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00029"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-1342-6"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199602000-00023"},{"key":"e_1_2_4_41_1","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/JCM.36.9.2419-2422.1998","article-title":"Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1\u2010infected patients in southern Spain","volume":"36","author":"Pineda JA","year":"1998","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200101000-00006"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.5.1338"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89503-4"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034980057590"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90476-X"},{"key":"e_1_2_4_47_1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4269\/ajtmh.1993.48.666","article-title":"Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon\u2010gamma","volume":"48","author":"Squires KE","year":"1993","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_4_48_1","first-page":"345","article-title":"Visceral leishmaniasis \u2013 current therapeutic modalities","volume":"123","author":"Sundar S","year":"2006","journal-title":"The Indian Journal of Medical Research"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.992"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.5.1042"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200207010-00015"},{"key":"e_1_2_4_52_1","first-page":"49","article-title":"Leishmania\/HIV co\u2010infection. Epidemiological analysis of 692 retrospective cases","volume":"72","author":"World Health Organization","year":"1997","journal-title":"Weekly Epidemiological Record"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2009.02329.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2009.02329.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:29:40Z","timestamp":1696962580000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2009.02329.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,24]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-3156.2009.02329.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2009.02329.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,24]]}}}